BMJ Best Practice

参考文献

关键文献

Felty AR. Chronic arthritis in the adult associated with splenomegaly and leucopenia. Bull Johns Hopkins Hosp. 1924;35:16-20.

Campion G, Maddison PJ, Goulding N, et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore). 1990;69:69-80.

Balint GP, Balint PV. Felty's syndrome. Best Pract Res Clin Rheumatol. 2004;18:631-645.

参考文章

1.  Felty AR. Chronic arthritis in the adult associated with splenomegaly and leucopenia. Bull Johns Hopkins Hosp. 1924;35:16-20.

2.  Campion G, Maddison PJ, Goulding N, et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore). 1990;69:69-80.

3.  Bowman SJ, Bhavnani M, Geddes GC, et al. Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol. 1995;101:18-24.

4.  Hellmich B, Pinals RS, Loughran TP Jr, et al. New clues to accrue on neutropenia in rheumatoid arthritis. Clin Immunol. 2005;117:1-5.

5.  Sibley JT, Haga M, Visram DA, et al. The clinical course of Felty's syndrome compared to matched controls. J Rheumatol. 1991;18:1163-1167.

6.  Almoallim H, Klinkhoff A. Longterm outcome of treatment of Felty's syndrome with intramuscular gold: case reports and recommendations for management. J Rheumatol. 2005;32:20-26.

7.  Rosenstein ED, Kramer N. Felty's and pseudo-Felty's syndromes. Semin Arthritis Rheum. 1991;21:129-142.

8.  Balint GP, Balint PV. Felty's syndrome. Best Pract Res Clin Rheumatol. 2004;18:631-645.

9.  Wordsworth P, Pile KD, Buckley JD, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet. 1992;51:585-591.

10.  Coakley G, Brooks D, Iqbal M, et al. Major histocompatibility complex haplotypic associations in Felty's syndrome and large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB1 *0401. Rheumatology (Oxford). 2000;39:393-398.

11.  Coakley G, Iqbal M, Brooks D, et al. CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum. 2000;43:834-843.

12.  Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukaemia and Felty syndrome. Blood Rev. 2006;20:245-266.

13.  Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheumatology (Oxford). 2009;48:716-720.

14.  Breedveld FC, Fibbe WE, Cats A. Neutropenia and infections in Felty's syndrome. Br J Rheumatol. 1988;27:191-197.

15.  Bowman SJ, Sivakumaran M, Snowden N, et al. The large granular lymphocyte syndrome with rheumatoid arthritis: immunogenetic evidence for a broader definition of Felty's syndrome. Arthritis Rheum. 1994;37:1326-1330.

16.  Turesson C, Jacobsson LTH, Sturfelt G, et al. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis. 2007;66:59-64.

17.  Wassenberg S, Herborn G, Rau R. Methotrexate treatment in Felty's syndrome. Br J Rheumatol. 1998;37:908-911.

18.  Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia of Felty syndrome. Blood Rev. 1996;10:177-184.

19.  Talip F, Walker N, Khan W, et al. Treatment of Felty's syndrome with leflunomide. J Rheumatol. 2001;28:868-870.

20.  Ishikawa K, Tsukada Y, Tamura S, et al. Salazosulfapyridine-induced remission of Felty's syndrome along with significant reduction in neutrophil-bound immunoglobulin G. J Rheumatol. 2003;30:404-406.

21.  Dillon AM, Luthra HS, Conn DL, et al. Parenteral gold therapy in the Felty syndrome: experience with 20 patients. Medicine (Baltimore). 1986;65:107-112.

22.  Hellmich B, Schnabel A, Gross WL. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthritis Rheum. 1999;29:82-99.

23.  Sordet C, Gottenberg JE, Hellmich B, et al. Lack of efficacy of rituximab in Felty's syndrome. Ann Rheum Dis. 2005;64:332-333.

24.  Lekharaju V, Chattopadhyay C. Efficacy of rituximab in Felty's syndrome. Ann Rheum Dis. 2008;67:1352.

25.  Chandra PA, Margulis Y, Schiff C. Rituximab is useful in the treatment of Felty's syndrome. Am J Ther. 2008;15:321-322.

26.  Weinreb N, Rabinowitz A, Dellaripa PF. Beneficial response to rituximab in refractory Felty syndrome. J Clin Rheumatol. 2006;12:48.

27.  Laszlo J, Jones R, Silberman HR, et al. Splenectomy for Felty's syndrome: clinopathological study of 27 patients. Arch Intern Med. 1978;138:597-602.

28.  Ghavami A, Genevay S, Fulpius T, et al. Etanercept in treatment of Felty's syndrome. Ann Rheum Dis. 2005;64:1090-1091.

29.  Gridley G, Klippel JH, Hoover RN, et al. Incidence of cancer among men with the Felty syndrome. Ann Intern Med. 1994;120:35-39.

30.  Stock H, Kadry Z, Smith JP. Surgical management of portal hypertension in Felty's syndrome: a case report and literature review. J Hepatol. 2009;50:831-835.

使用此内容应接受我们的免责声明